日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The efficacy of oligonucleotide-based gene therapeutics in gene silencing

基于寡核苷酸的基因疗法在基因沉默中的疗效

期刊:Theranostics
影响因子:13.3
doi:10.7150/thno.121775
Patra, Christina; Hussein, Zain; Ace, Veronika D; Misnik, Elena V; Rybalko, Daria S; Salimova, Adeliia A; Ereshko, Daria S; Dubovichenko, Mikhail V; Nour, Moustapha A Y; Drozd, Valeriia S; Kolpashchikov, Dmitry M
表观遗传
发表日期：2026
文献求助 收藏

Real-world outcomes of lenvatinib plus pembrolizumab in intermediate- and poor-risk metastatic renal cell carcinoma

乐伐替尼联合帕博利珠单抗治疗中危和高危转移性肾细胞癌的真实世界疗效

期刊:Exploration of Targeted Antitumor Therapy
影响因子:
doi:10.37349/etat.2025.1002305
Tsimafeyeu, Ilya; Sultanbaev, Alexander; Dubovichenko, Daria; Murzalina, Makhabbat; Volkov, Alexander; Orlova, Rashida; Utyashev, Igor; Malina, Georgy; Gluzman, Mark
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2025
文献求助 收藏

Multivalent DNAzyme agents for cleaving folded RNA

用于切割折叠RNA的多价DNA酶试剂

期刊:Nucleic Acids Research
影响因子:13.1
doi:10.1093/nar/gkae295
Dubovichenko, Mikhail V; Batsa, Michael; Bobkov, Gleb A; Vlasov, Gleb S; El-Deeb, Ahmed A; Kolpashchikov, Dmitry M
发表日期：2024
文献求助 收藏

Specificity of oligonucleotide gene therapy (OGT) agents

寡核苷酸基因治疗（OGT）药物的特异性

期刊:Theranostics
影响因子:13.3
doi:10.7150/thno.77830
Nedorezova, Daria D; Dubovichenko, Mikhail V; Belyaeva, Ekaterina P; Grigorieva, Ekaterina D; Peresadina, Arina V; Kolpashchikov, Dmitry M
基因治疗
发表日期：2022
文献求助 收藏